Paula Traquina

Dynavax Technologies (United States) — United States

Medicine · Health Sciences

11h-index736citations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(6), COVID-19 Clinical Research Studies(5), Immune Response and Inflammation(4), Influenza Virus Research Studies(3), Antimicrobial Peptides and Activities(3)

Publications17 total

411. Phase 1/2 Trial of an Investigational Herpes Zoster Vaccine with CpG 1018® Adjuvant and Shingrix in Healthy Adults 50 to 69 Years of Age
Open Forum Infectious Diseases·2026Open Access
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
npj Vaccines·2022· 26 citedOpen Access
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P
The Journal of Infectious Diseases·2022· 6 citedOpen Access
Protection of Hamsters Challenged with SARS-CoV-2 Variants of Concern by Two Doses of MVC-COV1901 Vaccine Followed by a Single Dose of Beta Variant Version of MVC-COV1901
2021· 2 citedOpen Access
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Scientific Reports·2021· 45 citedOpen Access
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
2021· 9 citedOpen Access
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Scientific Reports·2020· 179 citedOpen Access
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
2020· 21 citedOpen Access
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells
International Immunopharmacology·2018· 26 cited
First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated
Clinical Pharmacology & Therapeutics·2017· 29 cited
Immunostimulatory DNA as a vaccine adjuvant
Expert Review of Vaccines·2007· 62 cited
One-Pot Synthesis, Purification, and Formulation of Bionanoparticle−CpG Oligodeoxynucleotide Hepatitis B Surface Antigen Conjugate Vaccine via Tangential Flow Filtration
Bioconjugate Chemistry·2007· 9 cited
Amb a 1–linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma
Journal of Allergy and Clinical Immunology·2002· 150 citedOpen Access
Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.
PubMed·1997· 25 cited
A novel adjuvanted Hepatitis B (HBV), Haemophilus influenzae type b(Hib), and Neisseria meningitidis Group C (MenC) combination vaccine for use in infants. • 708
Pediatric Research·1997Open Access
MF59 Adjuvant Enhances the Antibody Response to Recombinant Hepatitis B Surface Antigen Vaccine in Primates
The Journal of Infectious Diseases·1996· 99 citedOpen Access
Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.
Journal of Biological Chemistry·1986· 48 citedOpen Access

Frequent Co-authors

John D. Campbell(9), Luke Tzu-Chi Liu(6), Charles Chen(6), Robert L. Coffman(5), Jinyi Cheng(4), Chia-En Lien(4), Tsun‐Yung Kuo(4), Meei‐Yun Lin(4), Yi‐Jiun Lin(4), Gary Van Nest(3), Chung-Chin Wu(3), Wei-Hsuan Tang(3), Ya-Shan Chuang(3), Tsun-Yung Kuo(2), Meei-Yun Lin(2), Chung‐Guei Huang(2), Hui‐Ying Ko(2), Cheng‐Pu Sun(2), Yu-Chiuan Wang(2), Mi‐Hua Tao(2)